Loading clinical trials...
Loading clinical trials...
Peripheral arterial disease (PAD) constitutes a major public health burden. The incidence of PAD increases with age and is associated with other comorbid cardiovascular disorders. Atherosclerosis whic...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University of Oklahoma
NCT05624125 · Peripheral Artery Disease
NCT07487363 · Atherosclerotic Cardiovascular Diseases, Endothelial Dysfunction
NCT07283289 · Peripheral Artery Disease
NCT06212271 · Peripheral Artery Disease
NCT07460960 · Erectile Dysfunction Due to Arterial Disease, Atheroscleroses, and more
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions